Table 2.
Observed outcomes in each group during the period of follow-up.
| Studied population N = 414 | SC-group N = 95 | STM-group N = 99 | ITM-groupN = 220 | P-value | |
|---|---|---|---|---|---|
| Duration of follow-up (days) | 341 ± 194 | 437 ± 190 | 362 ± 207 | 276 ± 163 | <0.05 |
| Unplanned hospitalization | 99 (23.9%) | 35 (36.8%) | 34 (34.3%) | 30 (13.6%) | <0.05 |
| All-cause of mortality | 46 (11.1%) | 16 (16.8%) | 20 (20.2%) | 10 (4.5%) | <0.05 |
| Cardiovascular mortality | 30 (7.2%) | 8 (8.4%) | 15 (15.2%) | 7 (3.2%) | <0.05 |